It takes a long time, many different steps, and considerable cost, before a new drug can be approved for use as a medicine. One could be forgiven for thinking that, since billions of people across the ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-tar ...

PDA Publishes Revised Technical Report No. 56: A Clear, Phase Appropriate Roadmap for GMP Compliant Development of Biological Drug Substances Technical Report No. 56 (Revised 2026) outlines a ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

Uppsala, Sweden, March 12, 2026. Dicot Pharma AB announces that the company has successfully completed the development of LIB-01 as a tablet and initiated manufacturing of tablets ahead of the upcomin ...

Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript March 11, 2026 Codexis, Inc. beats earnings expectations. Reported EPS is $0.1056, expectations were $-0.03. Operator: Greetings. Welcome ...

Via Christi said employment opportunities could arise as the process plays out.

People being arrested by ICE and deported did follow the rules and were caught up in the crackdown anyway, writes parishioner ...

After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance aims to standardize the practice. But recent decisions call into question ...

Metabolites in tissue fluid offer important clues that could help predict infection risk among women who undergo breast ...